Pacira BioSciences, Inc. Common Stock (PCRX) is a publicly traded Healthcare sector company. As of July 22, 2026, PCRX trades at $25.55 with a market cap of $997.47M and a P/E ratio of 159.94. PCRX moved -0.85% today. Year to date, PCRX is -0.39%; over the trailing twelve months it is +16.28%. Its 52-week range spans $16.41 to $27.64. Analyst consensus is buy with an average price target of $29.75. Rallies surfaces PCRX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest PCRX news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $25.55 |
| Market Cap | $997.47M |
| P/E Ratio | 159.94 |
| EPS | $0.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $27.64 |
| 52-Week Low | $16.41 |
| Volume | 78.25K |
| Avg Volume | 0 |
| Revenue (TTM) | $726.41M |
| Net Income | $7.03M |
| Gross Margin | 79.39% |
5 analysts cover PCRX: 0 strong buy, 3 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $29.75.